Patent 7282602 was granted and assigned to BioNumerik Pharmaceuticals on October, 2007 by the United States Patent and Trademark Office.
This invention relates to novel salts of medicinal disulfides. The compounds include a terminal sulfonate or phosphonate moiety, and have many uses, such as toxicity reducing agents when administered with many antineoplastic agents.